Abstract
A multigene family of human Ig-SF receptors and members of the murine Ly49 C-type lectin family are involved in natural killer (NK) cell-mediated recognition of MHC class I molecules. The human CD94 glycoprotein covalently assembles with different C-type lectins of the NKG2 family. By functional criteria, the CD94/ NKG2-A (kp43) receptor complex appears also involved in NK cell-mediated recognition of different HLA class I allotypes. Similarly to the other NK inhibitory receptors, NKG2-A contains cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs). By contrast, NK clones bearing a different receptor complex (CD94/ p39) are triggered upon ligation by CD94-specific monoclonal antibodies (MAbs); the p39 subunit is likely encoded by other member(s) of the NKG2 family. Expression of the different CD94/ NKG2 complexes is warranted to precisely assess their specific interaction with HLA class I molecules, and the molecular basis for their divergent functional properties.
Similar content being viewed by others
References
Ljunggren H-G, KÄrre K: In search of the missing self: MHC molecules and NK-cell recognition. Immunol Today 1990; 11:237–244.
Yokoyama WM: Natural killer cell receptors. Curr Opin Immunol 1995;7:110–120.
Lanier LL, Phillips JH: Inhibitory MHC class I receptors on NK-cells and T-cells. Immunol Today 1995; 17:86–91.
Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, Moretta L: Receptors for HLA class I molecules in human natural killer cells. Annu Rev Immunol 1996;14:619–648.
Malnati MS, Peruzzi M, Parker KC, Biddison WE, Ciccone E, Moretta A, Long EO: Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 1995;267:1016–1018.
Peruzzi M, Parker KC, Long EO, Malnati MS: Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J Immunol 1996; 157: 3350–3356.
Melero I, Salmerón A, Balboa MA, Aramburu J, López-Botet M: Tyrosine kinase-dependent activation of human NK-cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes. J Immunol 1994;152:1662–1673.
Döring C, Samaridis J, Colonna M: Alternatively sipliced forms of human killer inhibitory receptors. Immunogenetics 1996;3:227–230.
Bottino C, Sivori S, Vitale M, Cantoni C, Falco M, Pende D, Morelli L, Augugliaro R, Semenzato G, Biassoni R, Moretta L, Moretta A: A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur J Immunol 1996;26:1816–1824.
Pende D, Biassoni R, Cantoni C, Verdiani S, Falco M, Di Donate C, Accame O, Bottino C, Moretta A, Moretta L: The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/ p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kDa disulphide-linked dimer. J Exp Med 1996; 184:505–518.
Döhring C, Scheidegger D, Samaridis J, Cella M, Colonna M: A human killer inhibitory receptor specific for HLA-A: J Immunol 1996;156:3098–3101.
Lanier LL, Gumperz JE, Parham P, Melero I, López-Botet M, Phillips JH: The NKB 1 and HP-3E4 NK-cell receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. J Immunol 1995; 154: 3320–3327.
Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet J-P, Long EO: Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 1996;4:77–85.
Campbell KS, Dessing M, López-Botet M, Cella M, Colonna M: Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase lC. J Exp Med 1996;184:93–100.
Fry A, Lanier LL, Weiss A: Phosphotyrosines in the KIR motif of NKB1 are required for negative signaling and for association with PTP1C. J Exp Med 1996;184: 295–300.
Olcese L, Lang P, Vely F, Cambiaggi A, Marguet D, Blery M, Hippen KL, Biassoni R, Moretta A, Moretta L, Cambier JC, Vivier E: Human and mouse killer-cell inhibitory receptors recruit PTP1-C and PTP1-D protein tyrosine phos- phatases. J Immunol 1996; 156: 4531–4534.
Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, Bottino C, Moretta L. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C moleculesin human natural killer cells: J Exp Med 1995;182:875–884.
Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, Conte R, Poggi A, Moretta A, Moretta L: The HLA-C specific “activatory” or “inhibitory” natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 1996;183: 645–650.
López-Botet M, Moretta L, Stro-minger JL: NK-cell-receptors and recognition of MHC class-I molecules. Immunol Today 1996; 17: 212–214.
Lanier LL, Chang C, Phillips JH: Human NKR-P1A: A disulfidelinked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol 1994;153:2417–2428.
Düchler M, Offterdinger M, Holz-müller H, Lipp J, Chu C-T, Aschauer B, Bach FH, Hofer E: NKG2-C is a receptor on human natural killer cells that recognizes structures on K562 target cells. Eur J Immunol 1995;25:2923–2931.
Houchins JP, Yabe T, McSherry C, Bach FH: DNA sequence analy- sis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med 1991;173:1017–1020.
Yabe T, McSherry C, Bach FH, Fisch P, Schall RP, Sondel PM, Houchins JP: A multigene family on human chromosome 12 encodes natural killer cell-lectins. Immunogenetics 1993;37:455–460.
Adamkiewicz TV, McSherry C, Bach FH, Houchins JP: Natural killer lectin-like receptors have divergent carboxy-termini distinct from C-type lectins. Immunogenetics 1994;39:218–223.
Chang C, Rodriguez A, Carretero M, López-Botet M, Phillips J, Lanier LL: Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol 1995;25:2433–2437.
López-Cabrera M, Santis AG, Fernandez-Ruiz E, Blacher R, Esch F, Sánchez-Mateos P, Sanchez-Madrid F: Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J Exp Med 1993;178:537–547.
Moretta A, Vitale M, Sivori S, Bottino C, Morelli L, Augugliaro R, Barbaresi M, Pende D, Ciccone E, López-Botet M, Moretta L: Human natural killer cell receptors for HLA-class I molecules: Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med 1994; 180:545–555.
Sivori S, Vitale M, Bottino C, Marcenato E, Sanseverino L, Parolini S, Moretta L, Moretta A: CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alelles: Identification of the inhibitory form of CD94 by the use of novel mono- clonal antibodies. Eur J Immunol 1996;26:2487–2492.
Phillips JH, Chang C, Mattson J, Gumperz JE, Parham P, Lanier LL: CD94 and a novel associated protein (94AP) form a NK-cell receptor involved in the recognition of HLA-A, -B, and -C allotypes. Immunity 1996;5:163–172.
Aramburu J, Balboa MA, Ramírez A, Silva A, Acevedo A, Sánchez-Madrid F, de Landázuri MO, López-Botet M: A novel func- tional cell surface dimer (Kp43) expressed by natural killer cells and T-cell receptor-γ/δ+ T lymphocytes. Inhibition of IL-2 dependent proliferation by anti-Kp43 monoclonal antibody. J Immunol 1990; 144:3238–3247.
López-Botet M: CD94 cluster report: overview of the characterization of the Kp43 NK-cellassociated surface antigen; in Schlossman SF et al. (eds): Leucocyte Typing V. Oxford, UK, Oxford University Press, 1995, pp 1437–1439.
Acevedo A, Aramburu J, López J, Fernández-Herrera J, Fernández-Rañada JM, López-Botet M: Identification of natural killer (NK) cells in lesions of human cutaneous graft-versus-host disease: expression of a novel NK-associated surface antigen (Kp43) in mononuclear infiltrates. J Invest Dermatol 1991;97:659–666.
Mincheva-Nilsson L, Hammar-ström S, Hammarström ML: Human decidual leucocytes from early pregnancy contain high numbers of γδ+ cells and show selective down-regulation of alloreactivity. J Immunol 1992; 149:2203–2211.
Gudelj L, Deniz G, Rukavina D, Johnson PM, Christmas SE: Expression of functional mol- ecules by human CD3- decidual granular leucocyte clones. Immunology 1996;87:609–615.
Pérez-Villar JJ, Melero I, Rodrí-guez A, Carretero M, Aramburu J, Sivori S, Orengo AM, Moretta A, López-Botet M: Functional ambivalence of the Kp43 (CD94) NK-cell-associated surface antigen. J Immunol 1995;154:5779–5788.
Brumbaugh KM, Pérez-Villar JJ, Dick CJ, Schoon R, López-Botet M, Leibson PJ: Clonotypic differences in signaling from CD94 (Kp43) on NK-cells lead to divergent cellular responses. J Immunol 1996;157:2804–2812.
Pérez-Villar JJ, Carretero M, Navarro F, Melero I, Rodríguez A, Bottino C, Moretta A, López-Botet: Biochemical and serological evidence for the existence of functionally distinct isoforms of the CD94 NK-cell receptor. J Immunol 1996;157:5367–5374.
Rodriguez A, Corbi A, López-Botet M: Identification of new cDNA sequences belonging to the NKG2 family of genes expressed in NK-cells. Nat Immun 1992; 11:262.
Carretero M, Cantoni C, Bellón T, Bottino C, Biassoni R, Rodríguez A, Pérez-Villar J.J., Moretta L, Moretta A, López-Botet M: The CD94 and NKG2-A C-type lectins covalently assemble to form an NK-cell inhibitory receptor for HLA class I molecules. Eur J Immunol 1997;27:563–567.
Plougastel B, Jones T and Trows-dale J: Genomic structure, chomosome location and alternative splicing of the human NKG2-A gene. Immunogenetics 1996;44: 286–288.
Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH: Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 1996; 157:4741–4745.
Pérez-Villar J, Melero I, Navarro F, Cazzetero M, Bellén T, Llano M, Colonna M, Geraghty DE, López-Botet M: The CD94/MK62- A inhibitory receptor complex is involved in NK cell-mediated recognition of cells expressing HLA-G1. J Immunol, in press.
Pazmany L, Mandelboim O, Valés-Gomez M, Davis DM, Reyburn HT, Strominger JL: Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 1996;274: 792–794.
Daniels BF, Nakamura MC, Rosen SD, Yokoyama WM, Seaman WE: Ly-49A, a receptor for H-2Dd, has a functional carbohydrate recognition domain. Immunity 1995;1:785–792
Correa I, Raulet, DH: Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity 1995;2:61–71.
Storkus WJ, Salter RD, Cresswell P, Dawson JR: Peptide modulation of target sensitivity to natural killing. J Immunol 1992;149: 1185–1190.
Aramburu J, Balboa MA, Izquierdo M, López-Botet M: A novel functional cell surface dimer (Kp43) expressed by natural killer cells and γ/δ+ T lymphocytes. Modulation of natural killer cytotoxicity by anti Kp43 monoclonal antibody. J Immunol 1991;147:714–721.
Aramburu J, Balboa MA, Rodrí-guez A, Melero I, Alonso M, Alonso JL, López-Botet M: Stimulation of IL-2-activated natural killer cells through the Kp43 surface antigen up-regulates TNF-α production involving the LFA-1 integrin. J Immunol 1993; 151: 3420–3429.
Balboa MA, Balsinde J, Aramburu J, Mollinedo F, López-Botet M: Phospholipase Dactivation in human natural killer cells through the Kp43 and CD16 surface antigens takes place by different mechanisms. Involvement of the Phospholipase D pathway in tumor necrosis factor α synthesis. J Exp Med 1992;176:9–17.
Collins TL, Kassner PD, Bierer B, Burakoff SJ: Adhesion receptors in lymphocyte activation. Curr Opin Immunol 1994;6:385–393.
Thomas ML: Of ITAMs and ITIMs. Turning on and off the B cell antigen receptor. J Exp Med 1995;181:1953–1956.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
López-Botet, M., Carretero, M., Pérez-Villar, J.J. et al. The CD94/NKG2 C-type lectin receptor complex. Immunol Res 16, 175–185 (1997). https://doi.org/10.1007/BF02786361
Issue Date:
DOI: https://doi.org/10.1007/BF02786361